Abionyx Pharma SA (ABNX) Stock Price & News

ABNX:EPA

Abionyx Pharma SA

€1.55

-0.13%

(-0.0020) 1D

Nov 9, 10:41:01 AM GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for ABNX...

Open

€1.57

High

€1.57

Low

€1.54

Mkt. cap

68.22M

Avg. vol.

110.31K

Volume

9.19K

52-wk high

€4.53

52-wk low

€1.41

EPS

-€0.23

Shares outstanding

44.07M

No. of employees

Open

€1.57

High

€1.57

Low

€1.54

Mkt. cap

68.22M

Avg. vol.

110.31K

Volume

9.19K

52-wk high

€4.53

52-wk low

€1.41

EPS

-€0.23

Shares outstanding

44.07M

No. of employees

Related stocks

News stories

From web sources and news partners

FOREX.com

2 days ago

Nasdaq and S&P 500 Sink to Oversold While Silver Rebounds

TradingView

2 hours ago

SPX: S&P 500 Futures Edge Higher After Asia Stocks Power Up. Key AI Earnings Ahead

BigGo Finance

7 hours ago

Goldman Sachs Panic Index Breaches Extreme 9.5 Threshold; History Shows S&P 500 Averaged 4.6% Gain Over Following Three Months

CryptoRank

6 hours ago

S&P 500 Earnings Beats Shrink to Just 2.7%, Weakest in Four Years Despite 84% of Companies Topping Forecasts

About Abionyx Pharma SA

CEOCyrille Tupin

Employees49

Founded2005

Headquarters-

SectorHealth Care

IndustryBiotechnology

Websiteabionyx.com

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	1.06M	1.06M	972.00K	972.00K
Cost of goods sold	945.50K	945.50K	819.00K	819.00K
Cost of revenue	945.50K	945.50K	819.00K	819.00K
Research and development expenses	346.00K	346.00K	413.00K	413.00K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	938.00K	938.00K	1.35M	1.35M
Operating expense	1.28M	1.28M	1.76M	1.76M
Total operating expenses	2.22M	2.22M	2.58M	2.58M
Operating income	-1.16M	-1.16M	-1.60M	-1.60M
Other non operating income	11.00K	11.00K	-19.00K	-19.00K
EBT including unusual items	-1.15M	-1.15M	-1.62M	-1.62M
EBT excluding unusual items	-1.15M	-1.15M	-1.62M	-1.62M
Income tax expense	4.00K	4.00K	500.00	500.00
Effective tax rate	-0.35%	-0.35%	-0.03%	-0.03%
Other operating expenses	-5.00K	-5.00K	-5.00K	-5.00K
Net income	-1.15M	-1.15M	-1.62M	-1.62M
Net profit margin	-108.82%	-108.82%	-166.87%	-166.87%
Earnings per share	-	-	-	-
Interest and investment income	8.50K	8.50K	18.50K	18.50K
Interest expense	-26.50K	-26.50K	-16.00K	-16.00K
Net interest expenses	-18.00K	-18.00K	2.50K	2.50K
Depreciation and amortization charges	-	-	-	-
EBITDA	-1.13M	-1.13M	-1.58M	-1.58M
Gain or loss from assets sale	-	-	-	-

Ask anything